Vergoeding 2017-2021 voor ATC-subgroep N06AX : Overige antidepressiva
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| N06AX03 Mianserine | 58.727 | 38.852 | 41.612 | 25.827 | 24.431 |
| N06AX05 Trazodon (Trazolan ®) | 523.490 | 544.530 | 561.230 | 600.720 | 639.310 |
| N06AX11 Mirtazapine (Remeron ®) | 1.780.900 | 1.545.700 | 1.524.500 | 1.558.900 | 1.677.400 |
| N06AX12 Bupropion (Wellbutrin ®) | 4.627.600 | 5.078.600 | 5.420.600 | 5.778.200 | 4.759.100 |
| N06AX16 Venlafaxine (Efexor ®) | 3.447.100 | 3.505.600 | 3.695.100 | 3.774.600 | 3.562.700 |
| N06AX21 Duloxetine (Cymbalta ®) | 3.274.800 | 2.972.900 | 1.742.000 | 1.818.000 | 1.684.400 |
| N06AX22 Agomelatine (Valdoxan ®) | 941.850 | 855.280 | 669.380 | 506.580 | 431.650 |
| N06AX26 Vortioxetine (Brintellix ®) | 824.260 | 1.066.000 | 1.376.300 | 1.545.900 | 1.584.300 |
| Totaal | 15.478.727 | 15.607.462 | 15.030.722 | 15.608.727 | 14.363.291 |